Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease

The purpose of this review is to examine the possibilities and prospects for the use of direct oral anticoagulants for the prevention of thromboembolic complications in patients with atrial fibrillation and chronic kidney disease. Chronic kidney disease is an independent risk factor for cardiovascul...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko
Format: Artigo
Jezik:Inglês
Izdano: Stolichnaya Izdatelskaya Kompaniya 2019-09-01
Serija:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Teme:
atrial fibrillation
chronic kidney disease
direct oral anticoagulants
warfarin
Online dostop:https://www.rpcardio.com/jour/article/view/2006
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki